المؤلفون: Shiota M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan shiota@uro.med.kyushu-u.ac.jp., Nakamura M; Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan., Yokomizo A; Division of Urology, Harasanshin Hospital, Fukuoka, Japan., Tomoda T; Department of Urology, Oita Prefectural Hospital, Oita, Japan., Sakamoto N; Department of Urology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan., Seki N; Department of Urology, Kyushu Central Hospital, Fukuoka, Japan., Hasegawa S; Department of Urology, Kitakyushu Municipal Medical Center, Kitakyushu, Japan., Yunoki T; Department of Urology, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan., Harano M; Department of Urology, JCHO Kyushu Hospital, Kitakyushu, Japan., Kuroiwa K; Department of Urology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan., Eto M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

المصدر: Anticancer research [Anticancer Res] 2019 Aug; Vol. 39 (8), pp. 4411-4414.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Docetaxel/*administration & dosage , Prostatic Neoplasms, Castration-Resistant/*drug therapy , Taxoids/*administration & dosage, Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Docetaxel/adverse effects ; Drug Administration Schedule ; Humans ; Male ; Middle Aged ; Progression-Free Survival ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms, Castration-Resistant/blood ; Prostatic Neoplasms, Castration-Resistant/pathology ; Taxoids/adverse effects ; Treatment Outcome

المؤلفون: Schallier D; Department of Medical Oncology, Oncology Center UZ Brussels, Brussels, Belgium denis.schallier@uzbrussel.be., Rappe B; Department of Urology, General Municipal Hospital Aalst, Aalst, Belgium., Carprieaux M; Department of Pathology, General Municipal Hospital Aalst, Aalst, Belgium., Vandenbroucke F; Department of Radiology, Oncology Center UZ Brussels, Brussels, Belgium.

المصدر: Anticancer research [Anticancer Res] 2015 Nov; Vol. 35 (11), pp. 6317-20.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*adverse effects , Prostatic Neoplasms, Castration-Resistant/*drug therapy , Ureteral Neoplasms/*secondary, Abiraterone Acetate/administration & dosage ; Aged ; Docetaxel ; Humans ; Male ; Prednisone/administration & dosage ; Prognosis ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms, Castration-Resistant/blood ; Prostatic Neoplasms, Castration-Resistant/pathology ; Taxoids/administration & dosage ; Ureteral Neoplasms/chemically induced ; Ureteral Neoplasms/surgery

المؤلفون: Davies RS; Velindre Cancer Centre, Cardiff, Wales, U.K. rhian.s.davies@wales.nhs.uk., Smith C; Velindre Cancer Centre, Cardiff, Wales, U.K., Lester JF; Velindre Cancer Centre, Cardiff, Wales, U.K.

المصدر: Anticancer research [Anticancer Res] 2016 Apr; Vol. 36 (4), pp. 1799-803.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Androstenes/*therapeutic use , Antineoplastic Agents/*therapeutic use , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Phenylthiohydantoin/*analogs & derivatives , Prostatic Neoplasms, Castration-Resistant/*drug therapy , Taxoids/*therapeutic use, Aged ; Benzamides ; Docetaxel ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Nitriles ; Phenylthiohydantoin/therapeutic use ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms, Castration-Resistant/blood ; Treatment Outcome

المؤلفون: Petrioli R; Medical Oncology, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy r.petrioli@ao-siena.toscana.it., Francini E; Medical Oncology Unit, Policlinico Umberto I Hospital, University of Rome, Rome, Italy., Fiaschi AI; Pharmacology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy., Laera L; Medical Oncology, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy., Miano ST; Medical Oncology, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy., De Rubertis G; Urology Unit, Department of Genitourinary Diseases, University of Siena, Siena, Italy., Roviello G; Medical Oncology, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.

المصدر: Anticancer research [Anticancer Res] 2015 May; Vol. 35 (5), pp. 3097-102.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Androstenes/*administration & dosage , Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Prednisone/*administration & dosage , Prostatic Neoplasms, Castration-Resistant/*drug therapy, Abiraterone Acetate ; Aged, 80 and over ; Dose-Response Relationship, Drug ; Humans ; Male ; Neoplasm Staging ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms, Castration-Resistant/blood ; Prostatic Neoplasms, Castration-Resistant/mortality ; Prostatic Neoplasms, Castration-Resistant/pathology

المؤلفون: Park HS; Department of Urology, College of Medicine, Korea University, Guro Hospital, Seoul, Republic of Korea Korea University Center of Regenerative Medicine, Seoul, Republic of Korea., Hong SK; Department of Urology, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea., Oh MM; Department of Urology, College of Medicine, Korea University, Guro Hospital, Seoul, Republic of Korea Korea University Center of Regenerative Medicine, Seoul, Republic of Korea., Yoon CY; Department of Urology, College of Medicine, Korea University, Guro Hospital, Seoul, Republic of Korea Korea University Center of Regenerative Medicine, Seoul, Republic of Korea yoonyong@korea.ac.kr., Jeong SJ; Department of Urology, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea., Byun SS; Department of Urology, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea., Cheon J; Department of Urology, College of Medicine, Korea University, Anam Hospital, Seoul, Republic of Korea., Lee SE; Department of Urology, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea., Moon du G; Department of Urology, College of Medicine, Korea University, Guro Hospital, Seoul, Republic of Korea Korea University Center of Regenerative Medicine, Seoul, Republic of Korea.

المصدر: Anticancer research [Anticancer Res] 2014 Jul; Vol. 34 (7), pp. 3457-68.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*pharmacology , Imidazoles/*pharmacology , Indoles/*pharmacology , Prostatic Neoplasms, Castration-Resistant/*drug therapy , Pyrroles/*pharmacology , Quinolines/*pharmacology , Taxoids/*pharmacology, Apoptosis/drug effects ; Apoptosis Regulatory Proteins/biosynthesis ; Caspases/metabolism ; Cell Line, Tumor ; Docetaxel ; Dose-Response Relationship, Drug ; Drug Resistance, Neoplasm ; Drug Synergism ; Humans ; Male ; Phosphorylation ; Prostatic Neoplasms, Castration-Resistant/metabolism ; Prostatic Neoplasms, Castration-Resistant/pathology ; Proto-Oncogene Proteins c-akt/metabolism ; Sunitinib ; Vascular Endothelial Growth Factor Receptor-2/biosynthesis

المؤلفون: Schallier, Denis, Rappe, Bernard, Carprieaux, Marilyn, Frederik, Vandenbroucke

المساهمون: Laboratory of Molecular and Medical Oncology, Clinical sciences, Faculty of Medicine and Pharmacy, Medical Imaging

مصطلحات موضوعية: Male, Prostatic Neoplasms, Castration-Resistant, Ureteral Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Abiraterone Acetate, prednisone, Humans, Taxoids, Prostate-Specific Antigen, Prognosis, Aged

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3848::7804412ef9f14410c1f4b2913e7e2517
https://hdl.handle.net/20.500.14017/ea59cec4-ff4d-4cf8-b73f-4faf5b59dedf